Does lisinopril affect potassium
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Lisinopril on Potassium Levels
Introduction to Lisinopril and Potassium Regulation
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed for hypertension and heart failure. One of the notable effects of ACE inhibitors, including lisinopril, is their impact on potassium levels in the body. Understanding how lisinopril affects potassium is crucial, especially for patients with renal insufficiency or those at risk of hyperkalemia.
Lisinopril and Serum Potassium Levels
General Effects on Potassium
Lisinopril has been shown to increase serum potassium levels. This effect is primarily due to the inhibition of the renin-angiotensin-aldosterone system (RAAS), which reduces aldosterone secretion and subsequently decreases potassium excretion in the kidneys 17. In a study comparing lisinopril with valsartan, an angiotensin receptor blocker (ARB), it was found that lisinopril led to a more significant increase in serum potassium levels, particularly in patients with reduced glomerular filtration rates (GFR) 1.
Comparative Studies with Other Antihypertensive Agents
Several studies have compared the effects of lisinopril with other antihypertensive agents on potassium levels. For instance, a study comparing lisinopril and hydrochlorothiazide found that lisinopril treatment resulted in a slight increase in serum potassium, whereas hydrochlorothiazide led to a decrease 8. Another study highlighted that the incidence of hyperkalemia was higher in patients treated with lisinopril compared to those treated with chlorthalidone or amlodipine 3.
Potassium Handling in Specific Populations
Patients with Renal Insufficiency
In patients with renal insufficiency, the impact of lisinopril on potassium levels is more pronounced. A study demonstrated that in patients with a GFR of ≤60 mL/min/1.73 m², lisinopril significantly increased serum potassium levels compared to valsartan 1. This suggests that careful monitoring of potassium levels is essential in this population to prevent hyperkalemia.
Diabetic Patients
For hypertensive patients with type II diabetes mellitus, the effects of lisinopril on potassium handling were compared with those of candesartan, an ARB. The study found no significant differences in renal potassium handling between the two drugs, although there was a trend towards higher potassium excretion with candesartan 4. This indicates that both ACE inhibitors and ARBs can affect potassium levels, but the extent may vary.
Interaction with Potassium Supplements and Diet
Potassium Supplements
The interaction between lisinopril and potassium supplements has also been studied. In a trial involving potassium citrate and potassium chloride supplements, it was observed that lisinopril pretreatment did not significantly alter the rise in plasma potassium levels after supplementation 2. This suggests that while lisinopril increases serum potassium, its interaction with acute potassium loads may not exacerbate hyperkalemia significantly.
Dietary Considerations
Dietary intake of potassium-rich foods, such as bananas, in conjunction with lisinopril, has been investigated in animal models. The results indicated that the combination did not cause significant drug-food interactions leading to hyperkalemia 6. However, patients are generally advised to monitor their dietary potassium intake while on lisinopril therapy.
Conclusion
Lisinopril, like other ACE inhibitors, tends to increase serum potassium levels by inhibiting the RAAS and reducing aldosterone secretion. This effect is more pronounced in patients with renal insufficiency and those at risk of hyperkalemia. Comparative studies with other antihypertensive agents and potassium supplements suggest that while lisinopril does raise potassium levels, careful monitoring and dietary management can mitigate the risk of hyperkalemia. For patients on lisinopril, regular monitoring of serum potassium is essential to ensure safe and effective treatment.
Sources and full results
Most relevant research papers on this topic
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.
In the presence of renal insufficiency, valsartan does not raise serum potassium levels as significantly as lisinopril, with a smaller reduction in plasma aldosterone.
RCT
Highly CitedKaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements
An acute load of potassium citrate increases red blood cell potassium uptake and kaliuresis more effectively than potassium chloride alone or pretreatment with lisinopril.
RCTClinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Hypokalemia and hyperkalemia are common in hypertensive patients, but their impact on mortality is unrelated to the specific effects of thiazide diuretics.
RCT
Rigorous JournalComparative Effects on Dynamic Renal Potassium Excretion of ACE Inhibition versus Angiotensin Receptor Blockade in Hypertensive Patients with Type II Diabetes Mellitus
No statistical differences were found in renal potassium handling between candesartan and lisinopril in patients with type II diabetes mellitus and preserved renal function.
RCTIncidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan).
Angiotensin II receptor blocker (Losartan) is less likely to cause hyperkalemia than ACEI (Lisinopril) in high-risk patients with a history of high normal serum potassium levels.
Non-RCTEffect of Antihipertensive Drugs And Banana (Musa Sp.) To Potassium Serum Levels of Hypertensive Wistar Rats Model
Captopril and lisinopril combined with bananas did not cause drug and food interactions in hypertensive Wistar rats.
RCT
Animal StudyElectrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups.
Bendrofluazide treatment decreases serum potassium, reduces initial insulin release and glucose disposal, while lisinopril treatment increases serum potassium and initial insulin response, but does not improve insulin sensitivity.
RCTA comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension
Lisinopril slightly improves diastolic blood pressure control and overall electrolyte balance compared to hydrochlorothiazide, both well-tolerated and well-tolerated medications.
RCTLisinopril administration improves insulin action in aged patients with hypertension.
Lisinopril administration reduces arterial blood pressure and improves insulin sensitivity in elderly hypertensive patients.
RCTEffects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Lisinopril reduces plasma fibrinogen levels, while other antihypertensive drugs do not, potentially impacting the overall risk profile of hypertensive patients.
RCT